We are live on
!
Find out more
TAM
TFG Asset Management Portfolio holdings
AUM
$509M
1-Year Est. Return
24.47%
This Fund
S&P 500
This Quarter
Est. Return
+24.94%
1 Year Est. Return
+24.47%
3 Year Est. Return
+54.92%
5 Year Est. Return
+65.34%
10 Year Est. Return
+105.07%
AUM
$474M
AUM Growth
-$214M
(-31%)
Cap. Flow
-$273M
Cap. Flow
% of AUM
-57.56%
Top 10 Holdings %
Top 10 Hldgs %
86.79%
Holding
52
New
9
Increased
7
Reduced
6
Closed
17
Top Buys
| 1 |
UiPath
PATH
|
+$7.78M |
| 2 |
Agios Pharmaceuticals
AGIO
|
+$5.68M |
| 3 |
Praxis Precision Medicines
PRAX
|
+$4.27M |
| 4 |
RAPT
RAPT Therapeutics
RAPT
|
+$4.09M |
| 5 |
Nektar Therapeutics
NKTR
|
+$3.88M |
Top Sells
| 1 |
Tarsus Pharmaceuticals
TARS
|
+$7.43M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$5.92M |
| 3 |
Scholar Rock
SRRK
|
+$4.39M |
| 4 |
TECX
Tectonic Therapeutic
TECX
|
+$3.82M |
| 5 |
Axsome Therapeutics
AXSM
|
+$2.73M |
Sector Composition
| 1 | Technology | 71.19% |
| 2 | Healthcare | 23.07% |
| 3 | Energy | 5.75% |
| 4 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UiPath
PATH
$6.19B
| $286M | 60.3% |
17,450,000
+500,000
| +3% | +$7.78M |
|
|
KGEI
2
Kolibri Global Energy
KGEI
$182M
| $27.3M | 5.75% |
6,934,504
-136,064
| -2% | -$592K |
|
3
Lyft
LYFT
$6.16B
| $19.4M | 4.08% |
1,000,000
| – | – |
|
|
AUTL
4
Autolus Therapeutics
AUTL
$402M
| $18.9M | 3.99% |
9,500,000
| – | – |
|
5
Sprinklr
CXM
$1.35B
| $17.1M | 3.61% |
2,200,000
| – | – |
|
6
Workiva
WK
$3.05B
| $12.9M | 2.73% |
150,000
| – | – |
|
7
Annexon
ANNX
$1.06B
| $10.2M | 2.15% |
2,032,455
-80,000
| -4% | -$306K |
|
|
8
Praxis Precision Medicines
PRAX
$8.88B
| $6.76M | 1.43% |
+22,952
| New | +$4.27M |
|
9
Celldex Therapeutics
CLDX
$3.01B
| $6.62M | 1.4% |
243,800
-59,800
| -20% | -$1.58M |
|
10
Arrowhead Research
ARWR
$10.1B
| $6.44M | 1.36% |
96,935
+15,094
| +18% | +$740K |
|
11
Pharvaris
PHVS
$2.46B
| $5.4M | 1.14% |
194,612
| – | – |
|
|
12
Axsome Therapeutics
AXSM
$12.2B
| $4.92M | 1.04% |
26,934
-19,522
| -42% | -$2.73M |
|
13
Dyne Therapeutics
DYN
$3.97B
| $4.85M | 1.02% |
247,997
+24,816
| +11% | +$470K |
|
|
MBX
14
MBX Biosciences
MBX
$2.89B
| $4.52M | 0.95% |
143,327
-34,513
| -19% | -$837K |
|
|
RAPT
15
DELISTED
RAPT Therapeutics
RAPT
| $4.46M | 0.94% |
+131,770
| New | +$4.09M |
|
|
16
Agios Pharmaceuticals
AGIO
$2.37B
| $4.41M | 0.93% |
+162,018
| New | +$5.68M |
|
17
Immunovant
IMVT
$8.19B
| $4.22M | 0.89% |
166,187
-22,192
| -12% | -$495K |
|
18
Alkermes
ALKS
$8.66B
| $3.95M | 0.83% |
141,172
+51,560
| +58% | +$1.54M |
|
|
FOLD
19
DELISTED
Amicus Therapeutics
FOLD
| $3.71M | 0.78% |
260,771
+139,559
| +115% | +$1.37M |
|
20
Amylyx Pharmaceuticals
AMLX
$1.98B
| $3.3M | 0.69% |
272,828
+14,586
| +6% | +$198K |
|
21
Harmony Biosciences
HRMY
$2.02B
| $3.1M | 0.65% |
+82,824
| New | +$2.72M |
|
|
22
Nektar Therapeutics
NKTR
$2.31B
| $2.93M | 0.62% |
+69,287
| New | +$3.88M |
|
23
Krystal Biotech
KRYS
$10.3B
| $2.91M | 0.61% |
11,814
+6,944
| +143% | +$1.46M |
|
|
MPLT
24
MapLight Therapeutics
MPLT
$1.69B
| $2.89M | 0.61% |
+164,525
| New | +$2.76M |
|
|
SLN
25
Silence Therapeutics
SLN
$494M
| $2.22M | 0.47% |
+365,369
| New | +$2.34M |
|
Similar funds
HNW
MCA
OA
PWMG
MC
WDG
B
OWP